TMBRQ — Trex Wind-Down Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$2.52m
- $0.08m
Brief: Timber Pharmaceuticals Reports Qtrly Diluted Net Loss Per Share Attributable To Common Stockholders $0.08
Brief: Timber Pharmaceuticals Reports Qtrly Loss Per Share $0.08
Brief: Timber Pharmaceuticals Announces Pricing Of $15 Mln Public Offering
Brief: Timber Pharma Reports Proposed Public Offering
Timber Pharma gains on positive results from skin disease treatment study
Brief: Timber Pharmaceuticals Reports Positive Top-Line Results From Phase 2B Control Study Evaluating Tmb-001 In Moderate To Severe Congenital Ichthyosis
Brief: Timber Pharmaceuticals - Positive Top-Line Results From Phase 2B Control Study Evaluating Tmb-001 In Moderate To Severe Congenital Ichthyosis
Brief: Timber Pharmaceuticals Announces Last Patient Last Visit In Phase 2B Control Study Evaluating Tmb-001 In Moderate To Severe Congenital Ichthyosis
Brief: Timber Pharmaceuticals - Qtrly Loss Per share $0.08
Brief: Timber Pharmaceuticals Announces Adjournment Of Annual Meeting
U.S. STOCKS ON THE MOVE-Vertex Energy, Tellurian, Best Buy Co, Boeing
U.S. STOCKS ON THE MOVE-Vertex Energy, Vir Biotech, Ford Motor
Timber Pharma: Up on early patient enrollment completion for genetic disorder trial
Brief: Timber Pharmaceuticals Announces Completion Of Patient Enrollment In Phase 2B CONTROL Study
Brief: Timber Pharmaceuticals Provides Business Update And Announces First Quarter 2021 Financial Results
Brief: Timber Pharmaceuticals Inc Files For Mixed Shelf Of Up To $100 Mln
Brief: Timber Pharmaceuticals Inc Files For Resale Of 7.8 Mln Shares Of Common Stock By The Selling Stockholders
Brief: Timber Pharmaceuticals Receives Decision To Grant Japanese Patent For Lead Asset TMB-001
Brief: Timber Pharmaceuticals Says John Koconis Appointed Chairman Of The Board